The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Lacidipine Market Research Report 2024
Synopsis
The global Lacidipine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Additionally, the growing focus on preventive healthcare and the rising demand for generic drugs are also contributing to market growth. Lacidipine is available in both generic and branded forms, offering patients cost-effective treatment options.Geographically, the lacidipine market is dominated by North America due to the high prevalence of hypertension in the region. However, other regions such as Europe, Asia Pacific, and Latin America are also witnessing significant growth, driven by an increasing population and rising healthcare expenditure.
This report aims to provide a comprehensive presentation of the global market for Lacidipine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lacidipine.
Report Scope
The Lacidipine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lacidipine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lacidipine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Dr. Reddy's Laboratories (UK)
Rivopharm
Pliva
West Coast
GSK
Creo Pharma
NIKSAN HEALTHCARE
Dideu Group
Incepta Pharmaceuticals
Synmosa Biopharma
Square Pharmaceuticals
Harbin Pharmaceutical Group
Zhejiang Better Pharmaceuticals
Hikma Pharmaceuticals
Consilient Health
Glenmark Pharmaceuticals
Segment by Type
2 mg
4 mg
6 mg
Segment by Application
Online Pharmacy
Offline Pharmacy
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Lacidipine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Lacidipine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Lacidipine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Additionally, the growing focus on preventive healthcare and the rising demand for generic drugs are also contributing to market growth. Lacidipine is available in both generic and branded forms, offering patients cost-effective treatment options.Geographically, the lacidipine market is dominated by North America due to the high prevalence of hypertension in the region. However, other regions such as Europe, Asia Pacific, and Latin America are also witnessing significant growth, driven by an increasing population and rising healthcare expenditure.
This report aims to provide a comprehensive presentation of the global market for Lacidipine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lacidipine.
Report Scope
The Lacidipine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lacidipine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lacidipine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Dr. Reddy's Laboratories (UK)
Rivopharm
Pliva
West Coast
GSK
Creo Pharma
NIKSAN HEALTHCARE
Dideu Group
Incepta Pharmaceuticals
Synmosa Biopharma
Square Pharmaceuticals
Harbin Pharmaceutical Group
Zhejiang Better Pharmaceuticals
Hikma Pharmaceuticals
Consilient Health
Glenmark Pharmaceuticals
Segment by Type
2 mg
4 mg
6 mg
Segment by Application
Online Pharmacy
Offline Pharmacy
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Lacidipine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Lacidipine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Lacidipine Market Overview
1.1 Product Overview and Scope of Lacidipine
1.2 Lacidipine Segment by Type
1.2.1 Global Lacidipine Market Value Comparison by Type (2024-2030)
1.2.2 2 mg
1.2.3 4 mg
1.2.4 6 mg
1.3 Lacidipine Segment by Application
1.3.1 Global Lacidipine Market Value by Application: (2024-2030)
1.3.2 Online Pharmacy
1.3.3 Offline Pharmacy
1.4 Global Lacidipine Market Size Estimates and Forecasts
1.4.1 Global Lacidipine Revenue 2019-2030
1.4.2 Global Lacidipine Sales 2019-2030
1.4.3 Global Lacidipine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Lacidipine Market Competition by Manufacturers
2.1 Global Lacidipine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Lacidipine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Lacidipine Average Price by Manufacturers (2019-2024)
2.4 Global Lacidipine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Lacidipine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Lacidipine, Product Type & Application
2.7 Lacidipine Market Competitive Situation and Trends
2.7.1 Lacidipine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Lacidipine Players Market Share by Revenue
2.7.3 Global Lacidipine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Lacidipine Retrospective Market Scenario by Region
3.1 Global Lacidipine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Lacidipine Global Lacidipine Sales by Region: 2019-2030
3.2.1 Global Lacidipine Sales by Region: 2019-2024
3.2.2 Global Lacidipine Sales by Region: 2025-2030
3.3 Global Lacidipine Global Lacidipine Revenue by Region: 2019-2030
3.3.1 Global Lacidipine Revenue by Region: 2019-2024
3.3.2 Global Lacidipine Revenue by Region: 2025-2030
3.4 North America Lacidipine Market Facts & Figures by Country
3.4.1 North America Lacidipine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Lacidipine Sales by Country (2019-2030)
3.4.3 North America Lacidipine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Lacidipine Market Facts & Figures by Country
3.5.1 Europe Lacidipine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Lacidipine Sales by Country (2019-2030)
3.5.3 Europe Lacidipine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lacidipine Market Facts & Figures by Country
3.6.1 Asia Pacific Lacidipine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Lacidipine Sales by Country (2019-2030)
3.6.3 Asia Pacific Lacidipine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Lacidipine Market Facts & Figures by Country
3.7.1 Latin America Lacidipine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Lacidipine Sales by Country (2019-2030)
3.7.3 Latin America Lacidipine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Lacidipine Market Facts & Figures by Country
3.8.1 Middle East and Africa Lacidipine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Lacidipine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Lacidipine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lacidipine Sales by Type (2019-2030)
4.1.1 Global Lacidipine Sales by Type (2019-2024)
4.1.2 Global Lacidipine Sales by Type (2025-2030)
4.1.3 Global Lacidipine Sales Market Share by Type (2019-2030)
4.2 Global Lacidipine Revenue by Type (2019-2030)
4.2.1 Global Lacidipine Revenue by Type (2019-2024)
4.2.2 Global Lacidipine Revenue by Type (2025-2030)
4.2.3 Global Lacidipine Revenue Market Share by Type (2019-2030)
4.3 Global Lacidipine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Lacidipine Sales by Application (2019-2030)
5.1.1 Global Lacidipine Sales by Application (2019-2024)
5.1.2 Global Lacidipine Sales by Application (2025-2030)
5.1.3 Global Lacidipine Sales Market Share by Application (2019-2030)
5.2 Global Lacidipine Revenue by Application (2019-2030)
5.2.1 Global Lacidipine Revenue by Application (2019-2024)
5.2.2 Global Lacidipine Revenue by Application (2025-2030)
5.2.3 Global Lacidipine Revenue Market Share by Application (2019-2030)
5.3 Global Lacidipine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Dr. Reddy's Laboratories (UK)
6.1.1 Dr. Reddy's Laboratories (UK) Corporation Information
6.1.2 Dr. Reddy's Laboratories (UK) Description and Business Overview
6.1.3 Dr. Reddy's Laboratories (UK) Lacidipine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Dr. Reddy's Laboratories (UK) Lacidipine Product Portfolio
6.1.5 Dr. Reddy's Laboratories (UK) Recent Developments/Updates
6.2 Rivopharm
6.2.1 Rivopharm Corporation Information
6.2.2 Rivopharm Description and Business Overview
6.2.3 Rivopharm Lacidipine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Rivopharm Lacidipine Product Portfolio
6.2.5 Rivopharm Recent Developments/Updates
6.3 Pliva
6.3.1 Pliva Corporation Information
6.3.2 Pliva Description and Business Overview
6.3.3 Pliva Lacidipine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pliva Lacidipine Product Portfolio
6.3.5 Pliva Recent Developments/Updates
6.4 West Coast
6.4.1 West Coast Corporation Information
6.4.2 West Coast Description and Business Overview
6.4.3 West Coast Lacidipine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 West Coast Lacidipine Product Portfolio
6.4.5 West Coast Recent Developments/Updates
6.5 GSK
6.5.1 GSK Corporation Information
6.5.2 GSK Description and Business Overview
6.5.3 GSK Lacidipine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 GSK Lacidipine Product Portfolio
6.5.5 GSK Recent Developments/Updates
6.6 Creo Pharma
6.6.1 Creo Pharma Corporation Information
6.6.2 Creo Pharma Description and Business Overview
6.6.3 Creo Pharma Lacidipine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Creo Pharma Lacidipine Product Portfolio
6.6.5 Creo Pharma Recent Developments/Updates
6.7 NIKSAN HEALTHCARE
6.6.1 NIKSAN HEALTHCARE Corporation Information
6.6.2 NIKSAN HEALTHCARE Description and Business Overview
6.6.3 NIKSAN HEALTHCARE Lacidipine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 NIKSAN HEALTHCARE Lacidipine Product Portfolio
6.7.5 NIKSAN HEALTHCARE Recent Developments/Updates
6.8 Dideu Group
6.8.1 Dideu Group Corporation Information
6.8.2 Dideu Group Description and Business Overview
6.8.3 Dideu Group Lacidipine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Dideu Group Lacidipine Product Portfolio
6.8.5 Dideu Group Recent Developments/Updates
6.9 Incepta Pharmaceuticals
6.9.1 Incepta Pharmaceuticals Corporation Information
6.9.2 Incepta Pharmaceuticals Description and Business Overview
6.9.3 Incepta Pharmaceuticals Lacidipine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Incepta Pharmaceuticals Lacidipine Product Portfolio
6.9.5 Incepta Pharmaceuticals Recent Developments/Updates
6.10 Synmosa Biopharma
6.10.1 Synmosa Biopharma Corporation Information
6.10.2 Synmosa Biopharma Description and Business Overview
6.10.3 Synmosa Biopharma Lacidipine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Synmosa Biopharma Lacidipine Product Portfolio
6.10.5 Synmosa Biopharma Recent Developments/Updates
6.11 Square Pharmaceuticals
6.11.1 Square Pharmaceuticals Corporation Information
6.11.2 Square Pharmaceuticals Lacidipine Description and Business Overview
6.11.3 Square Pharmaceuticals Lacidipine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Square Pharmaceuticals Lacidipine Product Portfolio
6.11.5 Square Pharmaceuticals Recent Developments/Updates
6.12 Harbin Pharmaceutical Group
6.12.1 Harbin Pharmaceutical Group Corporation Information
6.12.2 Harbin Pharmaceutical Group Lacidipine Description and Business Overview
6.12.3 Harbin Pharmaceutical Group Lacidipine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Harbin Pharmaceutical Group Lacidipine Product Portfolio
6.12.5 Harbin Pharmaceutical Group Recent Developments/Updates
6.13 Zhejiang Better Pharmaceuticals
6.13.1 Zhejiang Better Pharmaceuticals Corporation Information
6.13.2 Zhejiang Better Pharmaceuticals Lacidipine Description and Business Overview
6.13.3 Zhejiang Better Pharmaceuticals Lacidipine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Zhejiang Better Pharmaceuticals Lacidipine Product Portfolio
6.13.5 Zhejiang Better Pharmaceuticals Recent Developments/Updates
6.14 Hikma Pharmaceuticals
6.14.1 Hikma Pharmaceuticals Corporation Information
6.14.2 Hikma Pharmaceuticals Lacidipine Description and Business Overview
6.14.3 Hikma Pharmaceuticals Lacidipine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Hikma Pharmaceuticals Lacidipine Product Portfolio
6.14.5 Hikma Pharmaceuticals Recent Developments/Updates
6.15 Consilient Health
6.15.1 Consilient Health Corporation Information
6.15.2 Consilient Health Lacidipine Description and Business Overview
6.15.3 Consilient Health Lacidipine Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Consilient Health Lacidipine Product Portfolio
6.15.5 Consilient Health Recent Developments/Updates
6.16 Glenmark Pharmaceuticals
6.16.1 Glenmark Pharmaceuticals Corporation Information
6.16.2 Glenmark Pharmaceuticals Lacidipine Description and Business Overview
6.16.3 Glenmark Pharmaceuticals Lacidipine Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Glenmark Pharmaceuticals Lacidipine Product Portfolio
6.16.5 Glenmark Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lacidipine Industry Chain Analysis
7.2 Lacidipine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lacidipine Production Mode & Process
7.4 Lacidipine Sales and Marketing
7.4.1 Lacidipine Sales Channels
7.4.2 Lacidipine Distributors
7.5 Lacidipine Customers
8 Lacidipine Market Dynamics
8.1 Lacidipine Industry Trends
8.2 Lacidipine Market Drivers
8.3 Lacidipine Market Challenges
8.4 Lacidipine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Lacidipine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Lacidipine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Lacidipine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Lacidipine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Lacidipine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Lacidipine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Lacidipine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Lacidipine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Lacidipine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Lacidipine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Lacidipine, Product Type & Application
Table 12. Global Key Manufacturers of Lacidipine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Lacidipine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lacidipine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Lacidipine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Lacidipine Sales by Region (2019-2024) & (K Units)
Table 18. Global Lacidipine Sales Market Share by Region (2019-2024)
Table 19. Global Lacidipine Sales by Region (2025-2030) & (K Units)
Table 20. Global Lacidipine Sales Market Share by Region (2025-2030)
Table 21. Global Lacidipine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Lacidipine Revenue Market Share by Region (2019-2024)
Table 23. Global Lacidipine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Lacidipine Revenue Market Share by Region (2025-2030)
Table 25. North America Lacidipine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Lacidipine Sales by Country (2019-2024) & (K Units)
Table 27. North America Lacidipine Sales by Country (2025-2030) & (K Units)
Table 28. North America Lacidipine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Lacidipine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Lacidipine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Lacidipine Sales by Country (2019-2024) & (K Units)
Table 32. Europe Lacidipine Sales by Country (2025-2030) & (K Units)
Table 33. Europe Lacidipine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Lacidipine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Lacidipine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Lacidipine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Lacidipine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Lacidipine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Lacidipine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Lacidipine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Lacidipine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Lacidipine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Lacidipine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Lacidipine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Lacidipine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Lacidipine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Lacidipine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Lacidipine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Lacidipine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Lacidipine Sales (K Units) by Type (2019-2024)
Table 51. Global Lacidipine Sales (K Units) by Type (2025-2030)
Table 52. Global Lacidipine Sales Market Share by Type (2019-2024)
Table 53. Global Lacidipine Sales Market Share by Type (2025-2030)
Table 54. Global Lacidipine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Lacidipine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Lacidipine Revenue Market Share by Type (2019-2024)
Table 57. Global Lacidipine Revenue Market Share by Type (2025-2030)
Table 58. Global Lacidipine Price (US$/Unit) by Type (2019-2024)
Table 59. Global Lacidipine Price (US$/Unit) by Type (2025-2030)
Table 60. Global Lacidipine Sales (K Units) by Application (2019-2024)
Table 61. Global Lacidipine Sales (K Units) by Application (2025-2030)
Table 62. Global Lacidipine Sales Market Share by Application (2019-2024)
Table 63. Global Lacidipine Sales Market Share by Application (2025-2030)
Table 64. Global Lacidipine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Lacidipine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Lacidipine Revenue Market Share by Application (2019-2024)
Table 67. Global Lacidipine Revenue Market Share by Application (2025-2030)
Table 68. Global Lacidipine Price (US$/Unit) by Application (2019-2024)
Table 69. Global Lacidipine Price (US$/Unit) by Application (2025-2030)
Table 70. Dr. Reddy's Laboratories (UK) Corporation Information
Table 71. Dr. Reddy's Laboratories (UK) Description and Business Overview
Table 72. Dr. Reddy's Laboratories (UK) Lacidipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Dr. Reddy's Laboratories (UK) Lacidipine Product
Table 74. Dr. Reddy's Laboratories (UK) Recent Developments/Updates
Table 75. Rivopharm Corporation Information
Table 76. Rivopharm Description and Business Overview
Table 77. Rivopharm Lacidipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Rivopharm Lacidipine Product
Table 79. Rivopharm Recent Developments/Updates
Table 80. Pliva Corporation Information
Table 81. Pliva Description and Business Overview
Table 82. Pliva Lacidipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Pliva Lacidipine Product
Table 84. Pliva Recent Developments/Updates
Table 85. West Coast Corporation Information
Table 86. West Coast Description and Business Overview
Table 87. West Coast Lacidipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. West Coast Lacidipine Product
Table 89. West Coast Recent Developments/Updates
Table 90. GSK Corporation Information
Table 91. GSK Description and Business Overview
Table 92. GSK Lacidipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. GSK Lacidipine Product
Table 94. GSK Recent Developments/Updates
Table 95. Creo Pharma Corporation Information
Table 96. Creo Pharma Description and Business Overview
Table 97. Creo Pharma Lacidipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Creo Pharma Lacidipine Product
Table 99. Creo Pharma Recent Developments/Updates
Table 100. NIKSAN HEALTHCARE Corporation Information
Table 101. NIKSAN HEALTHCARE Description and Business Overview
Table 102. NIKSAN HEALTHCARE Lacidipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. NIKSAN HEALTHCARE Lacidipine Product
Table 104. NIKSAN HEALTHCARE Recent Developments/Updates
Table 105. Dideu Group Corporation Information
Table 106. Dideu Group Description and Business Overview
Table 107. Dideu Group Lacidipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Dideu Group Lacidipine Product
Table 109. Dideu Group Recent Developments/Updates
Table 110. Incepta Pharmaceuticals Corporation Information
Table 111. Incepta Pharmaceuticals Description and Business Overview
Table 112. Incepta Pharmaceuticals Lacidipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Incepta Pharmaceuticals Lacidipine Product
Table 114. Incepta Pharmaceuticals Recent Developments/Updates
Table 115. Synmosa Biopharma Corporation Information
Table 116. Synmosa Biopharma Description and Business Overview
Table 117. Synmosa Biopharma Lacidipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Synmosa Biopharma Lacidipine Product
Table 119. Synmosa Biopharma Recent Developments/Updates
Table 120. Square Pharmaceuticals Corporation Information
Table 121. Square Pharmaceuticals Description and Business Overview
Table 122. Square Pharmaceuticals Lacidipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Square Pharmaceuticals Lacidipine Product
Table 124. Square Pharmaceuticals Recent Developments/Updates
Table 125. Harbin Pharmaceutical Group Corporation Information
Table 126. Harbin Pharmaceutical Group Description and Business Overview
Table 127. Harbin Pharmaceutical Group Lacidipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Harbin Pharmaceutical Group Lacidipine Product
Table 129. Harbin Pharmaceutical Group Recent Developments/Updates
Table 130. Zhejiang Better Pharmaceuticals Corporation Information
Table 131. Zhejiang Better Pharmaceuticals Description and Business Overview
Table 132. Zhejiang Better Pharmaceuticals Lacidipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Zhejiang Better Pharmaceuticals Lacidipine Product
Table 134. Zhejiang Better Pharmaceuticals Recent Developments/Updates
Table 135. Hikma Pharmaceuticals Corporation Information
Table 136. Hikma Pharmaceuticals Description and Business Overview
Table 137. Hikma Pharmaceuticals Lacidipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Hikma Pharmaceuticals Lacidipine Product
Table 139. Hikma Pharmaceuticals Recent Developments/Updates
Table 140. Consilient Health Corporation Information
Table 141. Consilient Health Description and Business Overview
Table 142. Consilient Health Lacidipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Consilient Health Lacidipine Product
Table 144. Consilient Health Recent Developments/Updates
Table 145. Glenmark Pharmaceuticals Corporation Information
Table 146. Glenmark Pharmaceuticals Description and Business Overview
Table 147. Glenmark Pharmaceuticals Lacidipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Glenmark Pharmaceuticals Lacidipine Product
Table 149. Glenmark Pharmaceuticals Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Lacidipine Distributors List
Table 153. Lacidipine Customers List
Table 154. Lacidipine Market Trends
Table 155. Lacidipine Market Drivers
Table 156. Lacidipine Market Challenges
Table 157. Lacidipine Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Lacidipine
Figure 2. Global Lacidipine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Lacidipine Market Share by Type in 2023 & 2030
Figure 4. 2 mg Product Picture
Figure 5. 4 mg Product Picture
Figure 6. 6 mg Product Picture
Figure 7. Global Lacidipine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Lacidipine Market Share by Application in 2023 & 2030
Figure 9. Online Pharmacy
Figure 10. Offline Pharmacy
Figure 11. Global Lacidipine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Lacidipine Market Size (2019-2030) & (US$ Million)
Figure 13. Global Lacidipine Sales (2019-2030) & (K Units)
Figure 14. Global Lacidipine Average Price (US$/Unit) & (2019-2030)
Figure 15. Lacidipine Report Years Considered
Figure 16. Lacidipine Sales Share by Manufacturers in 2023
Figure 17. Global Lacidipine Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Lacidipine Players: Market Share by Revenue in 2023
Figure 19. Lacidipine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Lacidipine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Lacidipine Sales Market Share by Country (2019-2030)
Figure 22. North America Lacidipine Revenue Market Share by Country (2019-2030)
Figure 23. United States Lacidipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Lacidipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Lacidipine Sales Market Share by Country (2019-2030)
Figure 26. Europe Lacidipine Revenue Market Share by Country (2019-2030)
Figure 27. Germany Lacidipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Lacidipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Lacidipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Lacidipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Lacidipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Lacidipine Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Lacidipine Revenue Market Share by Region (2019-2030)
Figure 34. China Lacidipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Lacidipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Lacidipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Lacidipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Lacidipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Lacidipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Lacidipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Lacidipine Sales Market Share by Country (2019-2030)
Figure 42. Latin America Lacidipine Revenue Market Share by Country (2019-2030)
Figure 43. Mexico Lacidipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Lacidipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Lacidipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Lacidipine Sales Market Share by Country (2019-2030)
Figure 47. Middle East & Africa Lacidipine Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Lacidipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Lacidipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Lacidipine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Lacidipine by Type (2019-2030)
Figure 52. Global Revenue Market Share of Lacidipine by Type (2019-2030)
Figure 53. Global Lacidipine Price (US$/Unit) by Type (2019-2030)
Figure 54. Global Sales Market Share of Lacidipine by Application (2019-2030)
Figure 55. Global Revenue Market Share of Lacidipine by Application (2019-2030)
Figure 56. Global Lacidipine Price (US$/Unit) by Application (2019-2030)
Figure 57. Lacidipine Value Chain
Figure 58. Lacidipine Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
